Cor Vasa 2022, 64(1):67-71 | DOI: 10.33678/cor.2021.066
(Diagnosis of laminopathy with predominant cardiac involvement during pretransplant assessment - a case report with a review of risk stratification and disease management of laminopathies)
- a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha
- b Ústav biologie a lékařské genetiky, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
We present a case of laminopathy, which was diagnosed in a sixteen-year-old female patient referred for heart transplant enlistment. In addition to advanced heart failure due to dilated cardiomyopathy, we detected mild contractures of elbow flexors. Molecular genetic analysis revealed a pathogenic variant of lamin A/C LMNA:c.241T>G, p.Tyr81Asp. These findings were compatible with Emery-Dreifuss myopathy with predominant cardiac involvement. Furthermore, we discuss clinical presentation of laminopathy, prognostic stratification of carriers of pathogenic LMNA variants and clinical management of patients with laminopathy.
Keywords: Cardiomyopathy, Emery-Dreifuss myopathy, Laminopathy,
Received: May 23, 2021; Revised: May 23, 2021; Accepted: June 6, 2021; Published: February 22, 2022 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Taylor MRG, Fain PR, Sinagra G, et al. Natural History of Dilated Cardiomyopathy Due to Lamin A/C Gene Mutations. J Am Coll Cardiol 2003;5:771-780.
Go to original source...
Go to PubMed...
- Van Tintelen JP, Hofstra RMW, Katerberg H, et al. High Yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease reffered to cardiogenetics outpatient clinics. Am Heart J 2007;12:1130-1139.
Go to original source...
Go to PubMed...
- Tesson F, Saj M, Uvaize MM, et al. Lamin A/C mutations in dilated cardiomyopathy. Cardiol J 2014;21:331-342.
Go to original source...
Go to PubMed...
- Feingold B, Mahle WT, Auerbach S, et al. Management of Cardiac Involment Associated With Neuromuscular Diseases. A Scientific Statement From the American Heart Association. Circulation 2017;9:200-231.
Go to original source...
Go to PubMed...
- Heller SA, Shih R, Kalra R, et al. Emery-Dreifuss muscular dystrophy. Muscle Nerve 2020;4:436-448.
Go to original source...
Go to PubMed...
- Haberlová J. Svalové dystrofie v dětském věku. Neurol pro Praxi 2019;20:171-178.
Go to original source...
- Rapezzi C, Arbustini E, Caforio ALP, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working group on Myocardial and Pericardial Diseases. Eur Heart J 2013;5:1448-1458.
Go to original source...
Go to PubMed...
- Van Rijsingen IAW, Arbustini E, Elliott PM, et al. Risk Factors of Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers. A European Cohort Study. J Am Coll Cardiol 2012;1:493-500.
Go to original source...
Go to PubMed...
- Priori AG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015;36:2793-2867.
Go to original source...
Go to PubMed...
- Wahbi K, Yaou RB, Gandjbakhch E, et al. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. Circulation 2019;140:293-302.
Go to original source...
Go to PubMed...
- Anselme F, Moubarak G, Savouré A, et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013;10:1492-8.
Go to original source...
Go to PubMed...
- Kumar S, Androulakis AFA, Sellal JM, et al. Multi-center Experience with Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy. Circ Arrhythm Electrophysiol 2016;9:e004357.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.